Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Total Equity Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Total Equity
$441.1m
CAGR 3-Years
2%
CAGR 5-Years
40%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Total Equity
$386.7m
CAGR 3-Years
-30%
CAGR 5-Years
-30%
CAGR 10-Years
-23%
Quest Diagnostics Inc
NYSE:DGX
Total Equity
$6.8B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Total Equity
$74.9B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Total Equity
$42.1B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
14%
Laboratory Corporation of America Holdings
NYSE:LH
Total Equity
$8.2B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
11%

See Also

What is Castle Biosciences Inc's Total Equity?
Total Equity
441.1m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Total Equity amounts to 441.1m USD.

What is Castle Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 5Y
40%

Over the last year, the Total Equity growth was 14%. The average annual Total Equity growth rates for Castle Biosciences Inc have been 2% over the past three years , 40% over the past five years .

Back to Top